You are here

CureVac

CureVac grabs $213M in US IPO, adding to year's record pace

BioPharma Dive

Fri, 08/14/20 - 09:44 am

GSK hands CureVac $294M to form mRNA infectious disease pact

Fierce Biotech

Mon, 07/20/20 - 10:42 am

monoclonal antibodies

After CureVac nabs government backing, BioNTech sees $250M private investment

Fierce Biotech

Mon, 06/29/20 - 10:21 am

CureVac gets OK to start testing mRNA COVID-19 vaccine in humans

Fierce Pharma

Wed, 06/17/20 - 10:06 am

clinical trials

Germany stakes its claim over Curevac

EP Vantage

Tue, 06/16/20 - 10:38 am

Crisis, what crisis? Curevac denies everything

EP Vantage

Tue, 03/17/20 - 12:10 pm

COVID-19 drugmaker switches CEOs for second time in 5 days

Bizjournals

Mon, 03/16/20 - 11:45 pm

Germany Tries to Stop U.S. Poaching German Firm Seeking Coronavirus Vaccine

Reuters

Sun, 03/15/20 - 02:05 pm

CureVac CEO replaced in midst of biotech's coronavirus push

BioPharma Dive

Thu, 03/12/20 - 10:48 pm

Daniel Menichella

CureVac and Yale Team Up for mRNA-Based Lung Therapies

BioSpace

Tue, 08/13/19 - 04:41 pm

Moderna’s Not the Only One: A Look at the mRNA Market

BioSpace

Mon, 02/4/19 - 09:55 am

Moderna Therapeutics

Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact

Xconomy

Thu, 10/19/17 - 06:03 pm

cancer vaccines

Boehringer pairs its lung cancer drug with a vaccine in $600M tie-up with CureVac

Fierce Biotech

Thu, 09/18/14 - 09:57 am

Boehringer Ingelheim

mRNA vaccines protect against viral infections in study

Pharmaceutical Business Review

Mon, 11/26/12 - 11:11 am

CureVac nears crossroads for therapeutic cancer vax

Fierce Biotech

Mon, 05/10/10 - 12:02 pm

Pages